Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Policy topic
No spam. Unsubscribe anytime.
Vancouver Public Schools holds first readings to allow nasal epinephrine and over‑the‑counter naloxone on campuses
Summary
The board reviewed first readings of Policy 3420 (anaphylaxis prevention) and Policy 3424 (opioid overdose reversal), reflecting WASDA model updates and recent state law changes; no votes were taken on those policies at the meeting.
Vancouver Public Schools held first readings of two health‑related policy updates at its regular board meeting.
Policy 3420, “Anaphylaxis prevention and response,” was presented as updated to align with the WASDA model policy and Washington House Bill 1608; the district said the update would allow schools to maintain a supply of epinephrine nasal spray in addition to autoinjectors.
Policy 3424, “Opioid‑related overdose reversal,” was presented as an update aligned to a WASDA model policy and RCW 28A.210.390. The presentation clarified that the proposed policy changes would permit any person, including students or staff, to carry opioid reversal medication (naloxone) with a prescription or, where applicable, over‑the‑counter.
The board treated both items as first readings; no vote was required at the meeting. Staff characterized these as updates to reflect model policy and state law changes; the board will consider formal action in a subsequent meeting.
Ending: The district said the first‑read policy materials are available for review and that the items will return for further board consideration.
